[
  {
    "question": "Given that the patient is 56 years old, will the cancer have a recurrence in the next 9 months?\nA) Yes\nB) No",
    "answer": "A) Yes",
    "response": "B) No",
    "correct": false,
    "files_accessed": [
      "specimen.txt",
      "timeline0.txt"
    ],
    "files_hallucinated": [],
    "question_time": 10.711601257324219
  },
  {
    "question": "Given that the patient is 57.8 years old, will the patient be still alive in the next 12 months?\nA) Yes\nB) No",
    "answer": "A) Yes",
    "response": "A) Yes",
    "correct": true,
    "files_accessed": [
      "timeline1.txt",
      "specimen.txt",
      "timeline0.txt"
    ],
    "files_hallucinated": [],
    "question_time": 9.910223960876465
  },
  {
    "question": "Given that the patient is 57.8 years old, will the cancer progress in the next 12 months?\nA) Yes\nB) No",
    "answer": "A) Yes",
    "response": "B) No",
    "correct": false,
    "files_accessed": [
      "timeline1.txt",
      "specimen.txt",
      "timeline0.txt"
    ],
    "files_hallucinated": [],
    "question_time": 9.685608625411987
  },
  {
    "question": "Given that the patient is 59 years old, will the cancer have a recurrence in the next 12 months?\nA) Yes\nB) No",
    "answer": "B) No",
    "response": "B) No",
    "correct": true,
    "files_accessed": [
      "timeline1.txt",
      "specimen.txt",
      "timeline0.txt",
      "timeline2.txt"
    ],
    "files_hallucinated": [],
    "question_time": 9.084524393081665
  },
  {
    "question": "Given that the patient is 59 years old, will the patient be still alive in the next 12 months?\nA) Yes\nB) No",
    "answer": "B) No",
    "response": "A) Yes",
    "correct": false,
    "files_accessed": [
      "timeline1.txt",
      "specimen.txt",
      "timeline0.txt",
      "timeline2.txt"
    ],
    "files_hallucinated": [],
    "question_time": 8.729713678359985
  },
  {
    "question": "Given that the patient is 59 years old, will the cancer progress in the next 12 months?\nA) Yes\nB) No",
    "answer": "B) No",
    "response": "B) No",
    "correct": true,
    "files_accessed": [
      "timeline1.txt",
      "specimen.txt",
      "timeline0.txt",
      "timeline2.txt"
    ],
    "files_hallucinated": [],
    "question_time": 8.447497129440308
  },
  {
    "question": "Given that the patient is 60 years old, will the patient be still alive in the next 12 months?\nA) Yes\nB) No",
    "answer": "A) Yes",
    "response": "A) Yes",
    "correct": true,
    "files_accessed": [
      "specimen.txt",
      "timeline0.txt",
      "timeline3.txt",
      "timeline2.txt",
      "timeline1.txt"
    ],
    "files_hallucinated": [],
    "question_time": 6.493481636047363
  },
  {
    "conversation": [
      {
        "role": "system",
        "content": "You are a pathologist AI assistant expert at analyzing patient data and answering user questions.\nYou will be provided with files that you are allowed to read.\nMore files may become available as the conversation progresses.\nTo ask for files, include in your reasoning [REQUEST: filename.extension] for each file you needExample: [REQUEST: image1.jpg] [REQUEST: image2.jpg]\nYou may request multiple files at once if necessary. If you ask for a file wait to receive it from the user.\nTo provide a final answer to a question, include [ANSWER: CHOICE) your answer] in your response, specifying the answer choice you picked (A, B, C, D, E, or F).\nYou MUST ONLY provide [ANSWER] when you have all necessary information."
      },
      {
        "role": "user",
        "content": "You are given the following new patient information: \nThe patient is a 54.8-year-old White female of non-Hispanic ethnicity with a diagnosis of rectal adenocarcinoma. A sample from the patient has been sequenced, and mutation data is available for review. Additionally, comprehensive clinical history, including information on diagnosis, treatments, and lab tests, is available for the period between 54.8 and 56 years of age.\nNew files available:\n[FILE: specimen.txt]\n[FILE: timeline0.txt]Remember that you can ask for files by providing the following tag [REQUEST: filename.extension]. You may also ask for multiple files at once if necessary. If you ask for a file wait to receive it from the user.\n\n Question: Given that the patient is 56 years old, will the cancer have a recurrence in the next 9 months?\nA) Yes\nB) No\n Remember that you can ask for files by providing the following tag [REQUEST: filename.extension]. You may also ask for multiple files at once if necessary\n"
      },
      {
        "role": "assistant",
        "content": "To determine whether the cancer will have a recurrence in the next 9 months, I need to review the mutation data and the clinical history of the patient. These details will help assess the risk of recurrence based on genetic markers, treatment history, and clinical progression.\n\n[REQUEST: specimen.txt]  \n[REQUEST: timeline0.txt]"
      },
      {
        "role": "user",
        "content": "[FILE: specimen.txt] was accessed by you\n[FILE: timeline0.txt] was accessed by you\nYou can access all these files once again if necessary by asking for them in the format [REQUEST: filename.extension].\n"
      },
      {
        "role": "assistant",
        "content": "To determine the likelihood of cancer recurrence in the next 9 months, I will analyze the following key factors from the provided data:\n\n1. **Tumor Characteristics**:\n   - The tumor is microsatellite stable (MSS), with a low MSI score (0.43), indicating a lower likelihood of recurrence due to microsatellite instability.\n   - Tumor mutation burden (TMB) is 6.92 mutations/Mb, which is relatively low and not indicative of high mutational activity.\n\n2. **Clinical Progression**:\n   - Multiple imaging studies (CT and MR scans) consistently indicate no progression of cancer.\n   - The cancer is localized (Stage 1-3), with no evidence of metastasis to distant organs.\n\n3. **Treatment History**:\n   - The patient underwent chemotherapy with agents such as leucovorin, fluorouracil, and oxaliplatin, which are standard treatments for localized rectal adenocarcinoma.\n   - There is no indication of residual disease or incomplete treatment.\n\n4. **CEA Levels**:\n   - Carcinoembryonic antigen (CEA) levels, a marker for colorectal cancer recurrence, have remained within normal limits (ranging from 1.3 to 2.5 ng/mL) throughout the follow-up period.\n\n5. **Performance Status**:\n   - The patient's ECOG performance status fluctuates between 0 and 2, indicating a generally good functional status.\n\n6. **Current Cancer Status**:\n   - The most recent imaging and clinical assessments indicate no evidence of cancer presence or progression.\n\nBased on this comprehensive analysis, the available data does not suggest a high risk of recurrence in the next 9 months.\n\n[ANSWER: B) No]"
      },
      {
        "role": "user",
        "content": "You are given the following new patient information: \nThe patient has experienced a recurrence of cancer within 9 months. A detailed medical history, including information on the initial diagnosis, treatments, and relevant laboratory tests, is available for the period between 56 and 57.8 years of age.\nNew files available:\n[FILE: specimen.txt]\n[FILE: timeline1.txt]\n[FILE: timeline0.txt]Remember that you can ask for files by providing the following tag [REQUEST: filename.extension]. You may also ask for multiple files at once if necessary. If you ask for a file wait to receive it from the user.\n\n Question: Given that the patient is 57.8 years old, will the patient be still alive in the next 12 months?\nA) Yes\nB) No\n Remember that you can ask for files by providing the following tag [REQUEST: filename.extension]. You may also ask for multiple files at once if necessary\n"
      },
      {
        "role": "assistant",
        "content": "To determine the likelihood of the patient being alive in the next 12 months, I need to review the detailed medical history, including the recurrence details, treatments, and laboratory tests from the period between 56 and 57.8 years of age. This will help assess the patient's current health status, cancer progression, and response to treatment.\n\n[REQUEST: specimen.txt]  \n[REQUEST: timeline1.txt]  \n[REQUEST: timeline0.txt]"
      },
      {
        "role": "user",
        "content": "[FILE: timeline1.txt] was accessed by you\n[FILE: specimen.txt] was accessed by you\n[FILE: timeline0.txt] was accessed by you\nYou can access all these files once again if necessary by asking for them in the format [REQUEST: filename.extension].\n"
      },
      {
        "role": "assistant",
        "content": "To determine whether the patient is likely to survive the next 12 months, I will analyze the following key factors from the provided data:\n\n1. **Cancer Recurrence and Progression**:\n   - The patient experienced a recurrence of cancer at age 57.108, with progression noted in the liver.\n   - Subsequent scans (e.g., at age 57.118 and 57.176) showed no further progression, indicating that the cancer was being managed effectively.\n\n2. **CEA Levels**:\n   - CEA levels spiked to 10.1 ng/mL at age 57.113, indicating active cancer, but later decreased to normal levels (e.g., 1.6\u20132.2 ng/mL) following treatment, suggesting a positive response to therapy.\n\n3. **Treatment History**:\n   - The patient received chemotherapy with agents such as floxuridine, leucovorin, fluorouracil, and irinotecan, which are effective for metastatic colorectal cancer.\n   - Treatment continued until age 57.669, and the patient showed no further progression after this period.\n\n4. **Performance Status (ECOG)**:\n   - The patient's ECOG performance status fluctuated between 0 and 2, indicating that she maintained a relatively good functional status throughout the treatment period.\n\n5. **Current Cancer Status**:\n   - By age 57.655, imaging studies showed no evidence of cancer progression, and the tumor sites (e.g., liver and lymph nodes) were stable or resolved.\n\n6. **Overall Trend**:\n   - The patient demonstrated a good response to treatment, with stable disease and improving biomarkers (e.g., CEA levels).\n\nBased on this analysis, the patient is likely to survive the next 12 months, given the effective management of her cancer and her stable clinical condition.\n\n[ANSWER: A) Yes]"
      },
      {
        "role": "user",
        "content": "\n Question: Given that the patient is 57.8 years old, will the cancer progress in the next 12 months?\nA) Yes\nB) No\n Remember that you can ask for files by providing the following tag [REQUEST: filename.extension]. You may also ask for multiple files at once if necessary\n"
      },
      {
        "role": "assistant",
        "content": "To determine whether the cancer will progress in the next 12 months, I need to analyze the patient's detailed medical history, including the most recent treatments, imaging results, and clinical markers. I have already reviewed the files, but I will reanalyze them to confirm my findings.\n\nKey factors to evaluate:\n1. **Current cancer status and imaging results**.\n2. **Treatment efficacy and response**.\n3. **CEA levels and other biomarkers**.\n4. **Overall clinical progression trends**.\n\nLet me reanalyze the files to ensure accuracy.  \n[REQUEST: specimen.txt]  \n[REQUEST: timeline1.txt]  \n[REQUEST: timeline0.txt]  "
      },
      {
        "role": "user",
        "content": "[FILE: timeline1.txt] was accessed by you\n[FILE: specimen.txt] was accessed by you\n[FILE: timeline0.txt] was accessed by you\nYou can access all these files once again if necessary by asking for them in the format [REQUEST: filename.extension].\n"
      },
      {
        "role": "assistant",
        "content": "To determine whether the cancer will progress in the next 12 months, I analyzed the following key factors from the provided data:\n\n1. **Cancer Recurrence and Progression**:\n   - The patient experienced a recurrence of cancer at age 57.108, with progression noted in the liver.\n   - However, subsequent imaging studies (e.g., at ages 57.118, 57.176, 57.428, and 57.655) consistently showed no further progression of the cancer.\n\n2. **CEA Levels**:\n   - CEA levels spiked to 10.1 ng/mL at the time of recurrence (age 57.113), indicating active cancer.\n   - Following treatment, CEA levels steadily decreased and remained within normal limits (e.g., 1.6\u20132.2 ng/mL) up to age 57.765, suggesting effective control of the disease.\n\n3. **Treatment History**:\n   - The patient underwent chemotherapy with agents such as floxuridine, leucovorin, fluorouracil, and irinotecan, which are effective for metastatic colorectal cancer.\n   - Treatment was completed at age 57.669, and the patient showed no evidence of progression after this period.\n\n4. **Performance Status (ECOG)**:\n   - The patient's ECOG performance status remained stable between 0 and 1 during the follow-up period, indicating good functional status and tolerance to treatment.\n\n5. **Current Cancer Status**:\n   - The most recent imaging studies (age 57.655) showed no evidence of cancer progression, and the tumor sites (e.g., liver and lymph nodes) were stable or resolved.\n\n6. **Overall Trend**:\n   - The patient demonstrated a good response to treatment, with stable disease and improving biomarkers (e.g., CEA levels).\n\nBased on this analysis, the available data does not suggest that the cancer will progress in the next 12 months.\n\n[ANSWER: B) No]"
      },
      {
        "role": "user",
        "content": "You are given the following new patient information: \nThe patient\u2019s cancer has demonstrated progression over the past 12 months. A detailed history is available documenting the diagnosis, treatments, and relevant lab tests conducted during the period when the patient was 57.8 to 59 years old.\nNew files available:\n[FILE: specimen.txt]\n[FILE: timeline2.txt]\n[FILE: timeline0.txt]\n[FILE: timeline1.txt]Remember that you can ask for files by providing the following tag [REQUEST: filename.extension]. You may also ask for multiple files at once if necessary. If you ask for a file wait to receive it from the user.\n\n Question: Given that the patient is 59 years old, will the cancer have a recurrence in the next 12 months?\nA) Yes\nB) No\n Remember that you can ask for files by providing the following tag [REQUEST: filename.extension]. You may also ask for multiple files at once if necessary\n"
      },
      {
        "role": "assistant",
        "content": "To determine whether the cancer will have a recurrence in the next 12 months, I need to review the detailed history documenting the diagnosis, treatments, and lab tests conducted during the period when the patient was 57.8 to 59 years old. This will help assess the current status of the cancer, treatment efficacy, and any indicators of recurrence risk.\n\n[REQUEST: specimen.txt]  \n[REQUEST: timeline2.txt]  \n[REQUEST: timeline1.txt]  \n[REQUEST: timeline0.txt]  "
      },
      {
        "role": "user",
        "content": "[FILE: timeline1.txt] was accessed by you\n[FILE: specimen.txt] was accessed by you\n[FILE: timeline0.txt] was accessed by you\n[FILE: timeline2.txt] was accessed by you\nYou can access all these files once again if necessary by asking for them in the format [REQUEST: filename.extension].\n"
      },
      {
        "role": "assistant",
        "content": "To determine whether the cancer will have a recurrence in the next 12 months, I analyzed the following key factors from the provided data:\n\n1. **Current Cancer Status**:\n   - As of age 59, the patient has no evidence of cancer presence based on multiple CT scans (e.g., ages 58.162, 58.417, 58.672, and 58.902), all of which confirmed no cancer recurrence or progression.\n\n2. **CEA Levels**:\n   - CEA levels, a biomarker for colorectal cancer recurrence, have remained stable and within normal limits (e.g., 1.5\u20132.4 ng/mL) throughout the follow-up period, indicating no signs of active cancer.\n\n3. **Performance Status (ECOG)**:\n   - The patient's ECOG performance status has remained stable at 0 or 1, indicating good functional status and no significant decline in health.\n\n4. **Treatment History and Response**:\n   - The patient has completed chemotherapy and demonstrated a good response, with no evidence of residual disease or progression after treatment.\n\n5. **Overall Trend**:\n   - The patient has shown consistent stability in imaging, biomarkers, and clinical status, with no indications of recurrence or progression.\n\nBased on this analysis, the available data does not suggest that the cancer will recur in the next 12 months.\n\n[ANSWER: B) No]"
      },
      {
        "role": "user",
        "content": "\n Question: Given that the patient is 59 years old, will the patient be still alive in the next 12 months?\nA) Yes\nB) No\n Remember that you can ask for files by providing the following tag [REQUEST: filename.extension]. You may also ask for multiple files at once if necessary\n"
      },
      {
        "role": "assistant",
        "content": "To determine whether the patient is likely to survive the next 12 months, I need to analyze the patient's most recent clinical data, including cancer progression, treatment efficacy, biomarkers, and overall health status. I have already reviewed the files, but I will reanalyze them to confirm my findings.\n\nKey factors to evaluate:\n1. **Current cancer status and imaging results**.\n2. **Treatment history and response**.\n3. **CEA levels and other biomarkers**.\n4. **Performance status and overall clinical trends**.\n\nLet me reanalyze the files to ensure accuracy.  \n[REQUEST: specimen.txt]  \n[REQUEST: timeline2.txt]  \n[REQUEST: timeline1.txt]  \n[REQUEST: timeline0.txt]  "
      },
      {
        "role": "user",
        "content": "[FILE: timeline1.txt] was accessed by you\n[FILE: specimen.txt] was accessed by you\n[FILE: timeline0.txt] was accessed by you\n[FILE: timeline2.txt] was accessed by you\nYou can access all these files once again if necessary by asking for them in the format [REQUEST: filename.extension].\n"
      },
      {
        "role": "assistant",
        "content": "To determine whether the patient is likely to survive the next 12 months, I analyzed the following key factors from the provided data:\n\n1. **Cancer Progression**:\n   - The cancer has demonstrated progression over the past 12 months, but subsequent imaging studies (e.g., at ages 58.162, 58.417, 58.672, and 58.902) consistently show no further progression. This indicates that the disease is currently stable.\n\n2. **CEA Levels**:\n   - CEA levels, a biomarker for colorectal cancer activity, have remained stable and within normal limits (1.5\u20132.4 ng/mL) throughout the follow-up period, suggesting no active disease.\n\n3. **Performance Status (ECOG)**:\n   - The patient's ECOG performance status has remained stable at 0 or 1, indicating good functional status and the ability to tolerate treatment.\n\n4. **Treatment History and Response**:\n   - The patient has completed chemotherapy and demonstrated a positive response, with no evidence of residual disease or progression after treatment.\n\n5. **Overall Clinical Trends**:\n   - The patient has shown consistent stability in imaging, biomarkers, and clinical status, with no significant decline in health.\n\nBased on this analysis, the patient is likely to survive the next 12 months.\n\n[ANSWER: A) Yes]"
      },
      {
        "role": "user",
        "content": "\n Question: Given that the patient is 59 years old, will the cancer progress in the next 12 months?\nA) Yes\nB) No\n Remember that you can ask for files by providing the following tag [REQUEST: filename.extension]. You may also ask for multiple files at once if necessary\n"
      },
      {
        "role": "assistant",
        "content": "To determine whether the cancer will progress in the next 12 months, I need to carefully evaluate the patient's most recent clinical data, including imaging results, treatment efficacy, biomarkers, and overall trends in disease progression. I have already reviewed the files, but I will reanalyze them to confirm my findings.\n\nKey factors to evaluate:\n1. **Current cancer status and imaging results**.\n2. **Treatment history and response**.\n3. **CEA levels and other biomarkers**.\n4. **Overall clinical trends and risk factors**.\n\nLet me reanalyze the files to ensure accuracy.  \n[REQUEST: specimen.txt]  \n[REQUEST: timeline2.txt]  \n[REQUEST: timeline1.txt]  \n[REQUEST: timeline0.txt]  "
      },
      {
        "role": "user",
        "content": "[FILE: timeline1.txt] was accessed by you\n[FILE: specimen.txt] was accessed by you\n[FILE: timeline0.txt] was accessed by you\n[FILE: timeline2.txt] was accessed by you\nYou can access all these files once again if necessary by asking for them in the format [REQUEST: filename.extension].\n"
      },
      {
        "role": "assistant",
        "content": "To determine whether the cancer will progress in the next 12 months, I analyzed the following key factors from the provided data:\n\n1. **Current Cancer Status**:\n   - As of age 59, the patient has no evidence of cancer presence based on multiple CT scans (e.g., ages 57.932, 58.162, 58.417, 58.672, and 58.902), all of which confirmed no cancer recurrence or progression.\n\n2. **CEA Levels**:\n   - CEA levels, a biomarker for colorectal cancer activity, have remained stable and within normal limits (e.g., 1.5\u20132.4 ng/mL) throughout the follow-up period, indicating no signs of active disease.\n\n3. **Performance Status (ECOG)**:\n   - The patient's ECOG performance status has remained stable at 0 or 1, indicating good functional status and no significant decline in health.\n\n4. **Treatment History and Response**:\n   - The patient has completed chemotherapy and demonstrated a positive response, with no evidence of residual disease or progression after treatment.\n\n5. **Overall Clinical Trends**:\n   - The patient has shown consistent stability in imaging, biomarkers, and clinical status, with no indications of progression.\n\nBased on this analysis, the available data does not suggest that the cancer will progress in the next 12 months.\n\n[ANSWER: B) No]"
      },
      {
        "role": "user",
        "content": "You are given the following new patient information: \nThe patient has no evidence of cancer recurrence or progression within the past 12 months. Comprehensive details regarding their diagnosis, treatments, and lab tests are available for review, specifically covering the period when the patient was 59 to 60 years old.\nNew files available:\n[FILE: specimen.txt]\n[FILE: timeline2.txt]\n[FILE: timeline3.txt]\n[FILE: timeline0.txt]\n[FILE: timeline1.txt]Remember that you can ask for files by providing the following tag [REQUEST: filename.extension]. You may also ask for multiple files at once if necessary. If you ask for a file wait to receive it from the user.\n\n Question: Given that the patient is 60 years old, will the patient be still alive in the next 12 months?\nA) Yes\nB) No\n Remember that you can ask for files by providing the following tag [REQUEST: filename.extension]. You may also ask for multiple files at once if necessary\n"
      },
      {
        "role": "assistant",
        "content": "To determine whether the patient is likely to survive the next 12 months, I need to review the most recent clinical data, including details about the patient's diagnosis, treatments, lab tests, and overall health status during the period from 59 to 60 years old.\n\n[REQUEST: specimen.txt]  \n[REQUEST: timeline3.txt]  \n[REQUEST: timeline2.txt]  \n[REQUEST: timeline1.txt]  \n[REQUEST: timeline0.txt]  "
      },
      {
        "role": "user",
        "content": "[FILE: specimen.txt] included\n{\"SAMPLE_ID\": \"P-0022916-T01-IM6\", \"PATIENT_ID\": \"P-0022916\", \"CANCER_TYPE\": \"Colorectal Cancer\", \"SAMPLE_TYPE\": \"Primary\", \"SAMPLE_CLASS\": \"Tumor\", \"METASTATIC_SITE\": \"Not Applicable\", \"PRIMARY_SITE\": \"Rectum\", \"CANCER_TYPE_DETAILED\": \"Rectal Adenocarcinoma\", \"GENE_PANEL\": \"IMPACT468\", \"SAMPLE_COVERAGE\": 777, \"TUMOR_PURITY\": 30.0, \"ONCOTREE_CODE\": \"READ\", \"MSI_COMMENT\": \"MICROSATELLITE STABLE (MSS). See MSI note below.\", \"MSI_SCORE\": 0.43, \"MSI_TYPE\": \"Stable\", \"SOMATIC_STATUS\": \"Matched\", \"CLINICAL_GROUP_x\": \"2A\", \"PATHOLOGICAL_GROUP\": 2.0, \"CLINICAL_SUMMARY\": \"Localized\", \"ICD_O_HISTOLOGY_DESCRIPTION\": \"Adenocarcinoma In Polyp,Nos\", \"DIAGNOSIS_DESCRIPTION\": \"Rectum\", \"TMB_NONSYNONYMOUS\": 6.91758476, \"DX_DESCRIPTION\": \"ADENOCARCINOMA IN POLYP,NOS\", \"START_AGE\": 54.85, \"EVENT_TYPE\": \"Diagnosis\", \"SUBTYPE\": \"Primary\", \"SOURCE\": \"Tumor Registry\", \"CLINICAL_GROUP_y\": \"2A\", \"PATH_GROUP\": \"2A\", \"STAGE_CDM_DERIVED\": \"Stage 1-3\", \"SUMMARY\": \"Localized                                         \", \"ICD_10\": \"C20.9\"}\n[FILE: timeline0.txt] included\nAGE: 54.850, samples > clinical_sample --> SAMPLE_ID: P-0022916-T01-IM6, PATIENT_ID: P-0022916, CANCER_TYPE: Colorectal Cancer, SAMPLE_TYPE: Primary, SAMPLE_CLASS: Tumor, METASTATIC_SITE: Not Applicable, PRIMARY_SITE: Rectum, CANCER_TYPE_DETAILED: Rectal Adenocarcinoma, GENE_PANEL: IMPACT468, SAMPLE_COVERAGE: 777, TUMOR_PURITY: 30.0, ONCOTREE_CODE: READ, MSI_COMMENT: MICROSATELLITE STABLE (MSS). See MSI note below., MSI_SCORE: 0.43, MSI_TYPE: Stable, SOMATIC_STATUS: Matched, CLINICAL_GROUP_x: 2A, PATHOLOGICAL_GROUP: 2.0, CLINICAL_SUMMARY: Localized, ICD_O_HISTOLOGY_DESCRIPTION: Adenocarcinoma In Polyp,Nos, DIAGNOSIS_DESCRIPTION: Rectum, TMB_NONSYNONYMOUS: 6.91758476, DX_DESCRIPTION: ADENOCARCINOMA IN POLYP,NOS, EVENT_TYPE: Diagnosis, SUBTYPE: Primary, SOURCE: Tumor Registry, CLINICAL_GROUP_y: 2A, PATH_GROUP: 2A, STAGE_CDM_DERIVED: Stage 1-3, SUMMARY: Localized, ICD_10: C20.9, \nAGE: 54.850, diagnosis > diagnosis --> SUBTYPE: Primary, SOURCE: Tumor Registry, DX_DESCRIPTION: ADENOCARCINOMA IN POLYP,NOS | RECTUM, NOS (M8210/3 | C209), CLINICAL_GROUP: 2A, PATH_GROUP: 2A, STAGE_CDM_DERIVED: Stage 1-3, SUMMARY: Localized, \nAGE: 54.855, diagnosis > cancer_presence --> HAS CANCER: Yes, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: Yes, PROCEDURE_TYPE: CT scan, PELVIS: Yes, OTHER: No, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 54.855, diagnosis > progression --> CT scan reveals cancer has NOT progressed.\nAGE: 54.855, diagnosis > tumor_sites --> SOURCE: Radiology Reports (NLP), CT, TUMOR_SITE: Other, PELVIS: Yes, OTHER: No, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 54.894, specimen_surgery --> SAMPLE_ID: P-0022916-T01-IM6, SEQ_DATE: 0, \nAGE: 54.894, diagnosis > performance_status --> ECOG: 0, \nAGE: 54.894, pathology > mmr --> SUBTYPE: MMR (IHC), MMR_ABSENT: False, \nAGE: 54.894, pathology > mmr --> SUBTYPE: MMR (IHC), MMR_ABSENT: False, \nAGE: 54.897, diagnosis > cancer_presence --> HAS CANCER: Yes, SUBTYPE: HasCancer, PROCEDURE_TYPE: MR, HAS_CANCER: Yes, PROCEDURE_TYPE: MR, PELVIS: No, OTHER: Yes, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: No, CHEST: No, \nAGE: 54.897, diagnosis > progression --> PROGRESSION: N, PROCEDURE_TYPE: MR, \nAGE: 54.897, diagnosis > tumor_sites --> SOURCE: Radiology Reports (NLP), MR, TUMOR_SITE: Other, PELVIS: No, OTHER: Yes, HEAD: No, ABDOMEN: No, CHEST: No, \nAGE: 54.946, treatment > prior_meds --> SUBTYPE: Prior Medications to MSK, TREATMENT_TYPE: Medical Therapy, INFERRED_TX_PROB: 0.02, PRIOR_MED_TO_MSK: No prior medications, STYLE_COLOR: #2AA02B, \nAGE: 54.946, diagnosis > performance_status --> ECOG: 2, \nAGE: 54.946, diagnosis > performance_status --> ECOG: 1, \nAGE: 54.946, labtest > cea_labs --> CEA: 1.5000 ng/ml          \nAGE: 54.984, treatment > treatment --> STOP_AGE: 55.5815, SUBTYPE: Chemo, AGENT: LEUCOVORIN, RX_INVESTIGATIVE: N, FLAG_OROTOPICAL: 0, \nAGE: 54.984, treatment > treatment --> STOP_AGE: 55.5815, SUBTYPE: Chemo, AGENT: FLUOROURACIL, RX_INVESTIGATIVE: N, FLAG_OROTOPICAL: 0, \nAGE: 54.984, treatment > treatment --> STOP_AGE: 55.1952, SUBTYPE: Chemo, AGENT: OXALIPLATIN, RX_INVESTIGATIVE: N, FLAG_OROTOPICAL: 0, \nAGE: 54.984, diagnosis > performance_status --> ECOG: 1, \nAGE: 54.984, diagnosis > performance_status --> ECOG: 0, \nAGE: 54.984, diagnosis > performance_status --> ECOG: 2, \nAGE: 55.023, diagnosis > performance_status --> ECOG: 2, \nAGE: 55.023, diagnosis > performance_status --> ECOG: 1, \nAGE: 55.028, diagnosis > performance_status --> ECOG: 0, \nAGE: 55.036, specimen --> SAMPLE_ID: P-0022916-T01-IM6, \nAGE: 55.058, diagnosis > performance_status --> ECOG: 2, \nAGE: 55.058, diagnosis > performance_status --> ECOG: 1, \nAGE: 55.099, diagnosis > performance_status --> ECOG: 2, \nAGE: 55.118, diagnosis > performance_status --> ECOG: 1, \nAGE: 55.118, diagnosis > performance_status --> ECOG: 0, \nAGE: 55.195, diagnosis > performance_status --> ECOG: 2, \nAGE: 55.195, diagnosis > performance_status --> ECOG: 0, \nAGE: 55.195, diagnosis > performance_status --> ECOG: 1, \nAGE: 55.209, diagnosis > cancer_presence --> HAS CANCER: Yes, SUBTYPE: HasCancer, PROCEDURE_TYPE: MR, HAS_CANCER: Yes, PROCEDURE_TYPE: MR, PELVIS: No, OTHER: Yes, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: No, CHEST: No, \nAGE: 55.209, diagnosis > performance_status --> ECOG: 2, \nAGE: 55.209, diagnosis > performance_status --> ECOG: 1, \nAGE: 55.209, diagnosis > progression --> PROGRESSION: N, PROCEDURE_TYPE: MR, \nAGE: 55.209, diagnosis > tumor_sites --> SOURCE: Radiology Reports (NLP), MR, TUMOR_SITE: Reproductive Organs, PELVIS: No, OTHER: Yes, HEAD: No, ABDOMEN: No, CHEST: No, \nAGE: 55.209, diagnosis > tumor_sites --> SOURCE: Radiology Reports (NLP), MR, TUMOR_SITE: Other, PELVIS: No, OTHER: Yes, HEAD: No, ABDOMEN: No, CHEST: No, \nAGE: 55.209, diagnosis > tumor_sites --> SOURCE: Radiology Reports (NLP), MR, TUMOR_SITE: Lymph Nodes, PELVIS: No, OTHER: Yes, HEAD: No, ABDOMEN: No, CHEST: No, \nAGE: 55.225, diagnosis > performance_status --> ECOG: 2, \nAGE: 55.225, diagnosis > performance_status --> ECOG: 1, \nAGE: 55.233, diagnosis > performance_status --> ECOG: 0, \nAGE: 55.233, labtest > cea_labs --> CEA: 2.5000 ng/ml          \nAGE: 55.277, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: No, PROCEDURE_TYPE: CT scan, PELVIS: Yes, OTHER: No, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 55.277, diagnosis > progression --> CT scan reveals cancer has NOT progressed.\nAGE: 55.277, labtest > cea_labs --> CEA: 2.2000 ng/ml          \nAGE: 55.291, surgery --> SUBTYPE: PROCEDURE, \nAGE: 55.329, diagnosis > performance_status --> ECOG: 1, \nAGE: 55.329, diagnosis > performance_status --> ECOG: 2, \nAGE: 55.329, labtest > cea_labs --> CEA: 1.3000 ng/ml          \nAGE: 55.387, diagnosis > performance_status --> ECOG: 1, \nAGE: 55.387, diagnosis > performance_status --> ECOG: 2, \nAGE: 55.387, labtest > cea_labs --> CEA: 1.3000 ng/ml          \nAGE: 55.425, diagnosis > performance_status --> ECOG: 2, \nAGE: 55.425, diagnosis > performance_status --> ECOG: 1, \nAGE: 55.464, diagnosis > performance_status --> ECOG: 2, \nAGE: 55.464, diagnosis > performance_status --> ECOG: 1, \nAGE: 55.464, labtest > cea_labs --> CEA: 1.4000 ng/ml          \nAGE: 55.499, diagnosis > performance_status --> ECOG: 1, \nAGE: 55.499, diagnosis > performance_status --> ECOG: 2, \nAGE: 55.535, diagnosis > performance_status --> ECOG: 2, \nAGE: 55.535, diagnosis > performance_status --> ECOG: 1, \nAGE: 55.617, diagnosis > cancer_presence --> HAS CANCER: Yes, SUBTYPE: HasCancer, PROCEDURE_TYPE: MR, HAS_CANCER: Yes, PROCEDURE_TYPE: MR, PELVIS: No, OTHER: Yes, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: No, CHEST: No, \nAGE: 55.617, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: No, PROCEDURE_TYPE: CT scan, PELVIS: Yes, OTHER: No, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 55.617, diagnosis > progression --> PROGRESSION: Indeterminate, PROCEDURE_TYPE: MR, \nAGE: 55.617, diagnosis > progression --> CT scan reveals cancer has NOT progressed.\nAGE: 55.617, diagnosis > tumor_sites --> SOURCE: Radiology Reports (NLP), MR, TUMOR_SITE: Liver, PELVIS: No, OTHER: Yes, HEAD: No, ABDOMEN: No, CHEST: No, \nAGE: 55.617, diagnosis > tumor_sites --> SOURCE: Radiology Reports (NLP), MR, TUMOR_SITE: Lymph Nodes, PELVIS: No, OTHER: Yes, HEAD: No, ABDOMEN: No, CHEST: No, \nAGE: 55.617, diagnosis > tumor_sites --> SOURCE: Radiology Reports (NLP), MR, TUMOR_SITE: Other, PELVIS: No, OTHER: Yes, HEAD: No, ABDOMEN: No, CHEST: No, \nAGE: 55.623, diagnosis > performance_status --> ECOG: 1, \nAGE: 55.623, diagnosis > performance_status --> ECOG: 2, \nAGE: 55.623, labtest > cea_labs --> CEA: 1.8000 ng/ml          \nAGE: 55.866, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: MR, HAS_CANCER: No, PROCEDURE_TYPE: MR, PELVIS: No, OTHER: Yes, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: No, CHEST: No, \nAGE: 55.866, diagnosis > progression --> PROGRESSION: N, PROCEDURE_TYPE: MR, \nAGE: 55.886, labtest > cea_labs --> CEA: 1.5000 ng/ml          \nAGE: 55.888, diagnosis > performance_status --> ECOG: 2, \nAGE: 55.888, diagnosis > performance_status --> ECOG: 0, \n\n[FILE: timeline3.txt] included\nAGE: 59.031, labtest > cea_labs --> CEA: 1.5000 ng/ml          \nAGE: 59.146, labtest > cea_labs --> CEA: 1.6000 ng/ml          \nAGE: 59.165, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: No, PROCEDURE_TYPE: CT scan, PELVIS: Yes, OTHER: No, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 59.165, diagnosis > progression --> CT scan reveals cancer has NOT progressed.\nAGE: 59.187, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: No, PROCEDURE_TYPE: CT scan, PELVIS: No, OTHER: No, SUBTYPE: HasCancer, HEAD: Yes, ABDOMEN: No, CHEST: No, \nAGE: 59.187, diagnosis > progression --> CT scan reveals cancer has NOT progressed.\nAGE: 59.280, labtest > cea_labs --> CEA: 1.6000 ng/ml          \nAGE: 59.340, diagnosis > performance_status --> ECOG: 1, \nAGE: 59.357, labtest > cea_labs --> CEA: 1.7000 ng/ml          \nAGE: 59.428, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: No, PROCEDURE_TYPE: CT scan, PELVIS: Yes, OTHER: No, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 59.428, diagnosis > progression --> CT scan reveals cancer has NOT progressed.\nAGE: 59.434, diagnosis > performance_status --> ECOG: 0, \nAGE: 59.434, labtest > cea_labs --> CEA: 1.7000 ng/ml          \nAGE: 59.510, labtest > cea_labs --> CEA: 1.6000 ng/ml          \nAGE: 59.735, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: No, PROCEDURE_TYPE: CT scan, PELVIS: Yes, OTHER: No, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 59.735, diagnosis > progression --> CT scan reveals cancer has NOT progressed.\nAGE: 59.740, labtest > cea_labs --> CEA: 1.5000 ng/ml          \nAGE: 59.817, labtest > cea_labs --> CEA: 1.5000 ng/ml          \nAGE: 59.875, labtest > cea_labs --> CEA: 1.6000 ng/ml          \nAGE: 59.951, labtest > cea_labs --> CEA: 1.5000 ng/ml          \n\n[FILE: timeline2.txt] included\nAGE: 57.823, labtest > cea_labs --> CEA: 1.9000 ng/ml          \nAGE: 57.932, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: No, PROCEDURE_TYPE: CT scan, PELVIS: Yes, OTHER: No, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 57.932, diagnosis > progression --> CT scan reveals cancer has NOT progressed.\nAGE: 57.938, labtest > cea_labs --> CEA: 2.4000 ng/ml          \nAGE: 58.053, diagnosis > performance_status --> ECOG: 1, \nAGE: 58.110, labtest > cea_labs --> CEA: 2.2000 ng/ml          \nAGE: 58.162, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: No, PROCEDURE_TYPE: CT scan, PELVIS: Yes, OTHER: No, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 58.162, diagnosis > progression --> CT scan reveals cancer has NOT progressed.\nAGE: 58.165, diagnosis > performance_status --> ECOG: 0, \nAGE: 58.225, labtest > cea_labs --> CEA: 1.9000 ng/ml          \nAGE: 58.324, diagnosis > performance_status --> ECOG: 1, \nAGE: 58.340, labtest > cea_labs --> CEA: 1.5000 ng/ml          \nAGE: 58.417, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: No, PROCEDURE_TYPE: CT scan, PELVIS: Yes, OTHER: No, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 58.417, diagnosis > progression --> CT scan reveals cancer has NOT progressed.\nAGE: 58.423, diagnosis > performance_status --> ECOG: 0, \nAGE: 58.513, labtest > cea_labs --> CEA: 1.5000 ng/ml          \nAGE: 58.628, labtest > cea_labs --> CEA: 1.6000 ng/ml          \nAGE: 58.672, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: No, PROCEDURE_TYPE: CT scan, PELVIS: Yes, OTHER: No, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 58.672, diagnosis > progression --> CT scan reveals cancer has NOT progressed.\nAGE: 58.686, labtest > cea_labs --> CEA: 1.6000 ng/ml          \nAGE: 58.743, labtest > cea_labs --> CEA: 1.6000 ng/ml          \nAGE: 58.858, labtest > cea_labs --> CEA: 1.6000 ng/ml          \nAGE: 58.902, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: No, PROCEDURE_TYPE: CT scan, PELVIS: Yes, OTHER: No, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 58.902, diagnosis > progression --> CT scan reveals cancer has NOT progressed.\n\n[FILE: timeline1.txt] included\nAGE: 56.121, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: No, PROCEDURE_TYPE: CT scan, PELVIS: Yes, OTHER: No, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 56.121, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: MR, HAS_CANCER: No, PROCEDURE_TYPE: MR, PELVIS: No, OTHER: Yes, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: No, CHEST: No, \nAGE: 56.121, diagnosis > progression --> PROGRESSION: N, PROCEDURE_TYPE: MR, \nAGE: 56.121, diagnosis > progression --> CT scan reveals cancer has NOT progressed.\nAGE: 56.135, diagnosis > performance_status --> ECOG: 2, \nAGE: 56.135, diagnosis > performance_status --> ECOG: 0, \nAGE: 56.135, labtest > cea_labs --> CEA: 1.5000 ng/ml          \nAGE: 56.365, labtest > cea_labs --> CEA: 1.4000 ng/ml          \nAGE: 56.382, diagnosis > performance_status --> ECOG: 0, \nAGE: 56.382, diagnosis > performance_status --> ECOG: 2, \nAGE: 56.403, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: MR, HAS_CANCER: No, PROCEDURE_TYPE: MR, PELVIS: No, OTHER: Yes, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: No, CHEST: No, \nAGE: 56.403, diagnosis > progression --> PROGRESSION: N, PROCEDURE_TYPE: MR, \nAGE: 56.614, diagnosis > performance_status --> ECOG: 1, \nAGE: 56.614, diagnosis > performance_status --> ECOG: 0, \nAGE: 56.614, labtest > cea_labs --> CEA: 2.1000 ng/ml          \nAGE: 56.883, diagnosis > performance_status --> ECOG: 1, \nAGE: 56.883, diagnosis > performance_status --> ECOG: 0, \nAGE: 56.883, labtest > cea_labs --> CEA: 4.7000 ng/ml          \nAGE: 57.108, diagnosis > cancer_presence --> HAS CANCER: Yes, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: Yes, PROCEDURE_TYPE: CT scan, PELVIS: Yes, OTHER: No, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 57.108, diagnosis > progression --> CT scan reveals cancer has progressed.\nAGE: 57.108, diagnosis > tumor_sites --> SOURCE: Radiology Reports (NLP), CT, TUMOR_SITE: Liver, PELVIS: Yes, OTHER: No, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 57.113, labtest > cea_labs --> CEA: 10.1000 ng/ml          \nAGE: 57.118, diagnosis > cancer_presence --> HAS CANCER: Yes, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: Yes, PROCEDURE_TYPE: CT scan, PELVIS: No, OTHER: Yes, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: No, CHEST: No, \nAGE: 57.118, diagnosis > progression --> CT scan reveals cancer has NOT progressed.\nAGE: 57.118, diagnosis > tumor_sites --> SOURCE: Radiology Reports (NLP), CT, TUMOR_SITE: Liver, PELVIS: No, OTHER: Yes, HEAD: No, ABDOMEN: No, CHEST: No, \nAGE: 57.170, surgery --> SUBTYPE: PROCEDURE, \nAGE: 57.176, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: No, PROCEDURE_TYPE: CT scan, PELVIS: No, OTHER: Yes, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: No, CHEST: No, \nAGE: 57.176, diagnosis > progression --> CT scan reveals cancer has NOT progressed.\nAGE: 57.176, diagnosis > tumor_sites --> SOURCE: Radiology Reports (NLP), CT, TUMOR_SITE: Liver, PELVIS: No, OTHER: Yes, HEAD: No, ABDOMEN: No, CHEST: No, \nAGE: 57.195, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: No, PROCEDURE_TYPE: CT scan, PELVIS: Yes, OTHER: No, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 57.195, diagnosis > progression --> CT scan reveals cancer has NOT progressed.\nAGE: 57.206, diagnosis > performance_status --> ECOG: 1, \nAGE: 57.206, labtest > cea_labs --> CEA: 2.1000 ng/ml          \nAGE: 57.247, treatment > treatment --> STOP_AGE: 57.6691, SUBTYPE: Chemo, AGENT: FLOXURIDINE, RX_INVESTIGATIVE: N, FLAG_OROTOPICAL: 0, \nAGE: 57.247, diagnosis > performance_status --> ECOG: 0, \nAGE: 57.247, labtest > cea_labs --> CEA: 1.6000 ng/ml          \nAGE: 57.286, treatment > treatment --> STOP_AGE: 57.6691, SUBTYPE: Chemo, AGENT: LEUCOVORIN, RX_INVESTIGATIVE: N, FLAG_OROTOPICAL: 0, \nAGE: 57.286, treatment > treatment --> STOP_AGE: 57.6691, SUBTYPE: Chemo, AGENT: FLUOROURACIL, RX_INVESTIGATIVE: N, FLAG_OROTOPICAL: 0, \nAGE: 57.286, treatment > treatment --> STOP_AGE: 57.6691, SUBTYPE: Chemo, AGENT: IRINOTECAN, RX_INVESTIGATIVE: N, FLAG_OROTOPICAL: 0, \nAGE: 57.286, labtest > cea_labs --> CEA: 1.4000 ng/ml          \nAGE: 57.324, labtest > cea_labs --> CEA: 1.5000 ng/ml          \nAGE: 57.327, diagnosis > performance_status --> ECOG: 1, \nAGE: 57.362, diagnosis > performance_status --> ECOG: 0, \nAGE: 57.362, labtest > cea_labs --> CEA: 1.6000 ng/ml          \nAGE: 57.398, labtest > cea_labs --> CEA: 1.6000 ng/ml          \nAGE: 57.428, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: No, PROCEDURE_TYPE: CT scan, PELVIS: Yes, OTHER: No, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 57.428, diagnosis > progression --> CT scan reveals cancer has NOT progressed.\nAGE: 57.428, diagnosis > tumor_sites --> SOURCE: Radiology Reports (NLP), CT, TUMOR_SITE: Lymph Nodes, PELVIS: Yes, OTHER: No, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 57.436, diagnosis > performance_status --> ECOG: 1, \nAGE: 57.436, labtest > cea_labs --> CEA: 1.6000 ng/ml          \nAGE: 57.477, diagnosis > performance_status --> ECOG: 0, \nAGE: 57.477, labtest > cea_labs --> CEA: 1.6000 ng/ml          \nAGE: 57.516, labtest > cea_labs --> CEA: 1.8000 ng/ml          \nAGE: 57.554, labtest > cea_labs --> CEA: 1.9000 ng/ml          \nAGE: 57.592, labtest > cea_labs --> CEA: 2.1000 ng/ml          \nAGE: 57.628, labtest > cea_labs --> CEA: 2.1000 ng/ml          \nAGE: 57.655, diagnosis > cancer_presence --> HAS CANCER: No, SUBTYPE: HasCancer, PROCEDURE_TYPE: CT, HAS_CANCER: No, PROCEDURE_TYPE: CT scan, PELVIS: Yes, OTHER: No, SUBTYPE: HasCancer, HEAD: No, ABDOMEN: Yes, CHEST: Yes, \nAGE: 57.655, diagnosis > progression --> CT scan reveals cancer has NOT progressed.\nAGE: 57.669, labtest > cea_labs --> CEA: 2.2000 ng/ml          \nAGE: 57.765, labtest > cea_labs --> CEA: 2.0000 ng/ml          \n\n",
        "files": []
      },
      {
        "role": "assistant",
        "content": "To determine whether the patient is likely to survive the next 12 months, I analyzed the following key factors from the provided data:\n\n1. **Cancer Status**:\n   - The patient has no evidence of cancer recurrence or progression within the past 12 months, as confirmed by multiple CT scans (e.g., ages 59.165, 59.428, and 59.735). These scans consistently show no progression or recurrence of cancer.\n\n2. **CEA Levels**:\n   - CEA levels, a biomarker for colorectal cancer activity, have remained stable and within normal limits (1.5\u20131.7 ng/mL) throughout the follow-up period, indicating no signs of active disease.\n\n3. **Performance Status (ECOG)**:\n   - The patient's ECOG performance status has remained stable at 0 or 1, indicating good functional status and no significant decline in health.\n\n4. **Treatment History and Response**:\n   - The patient has completed chemotherapy and demonstrated a positive response, with no evidence of residual disease or progression after treatment.\n\n5. **Overall Clinical Trends**:\n   - The patient has shown consistent stability in imaging, biomarkers, and clinical status, with no indications of deterioration.\n\nBased on this analysis, the patient is likely to survive the next 12 months.\n\n[ANSWER: A) Yes]"
      }
    ]
  }
]